Skip to main content
Premium Trial:

Request an Annual Quote

Iris, Fisher to Co-market FISH Sample Prep Technology

NEW YORK (GenomeWeb News) – Iris International late on Monday announced a deal between its Sample Processing division and Fisher Healthcare to co-market Iris' ThermoBrite Elite instrument for automated fluorescence in situ hybridization sample preparation.

Fisher, a part of Thermo Fisher Scientific, is the first commercial distribution partner for the instrument, Iris said.

Bill Standwill, VP of global sales and marketing for the Iris Sample Processing division, said in a statement that the ThermoBrite Elite instrument is a "natural line extension to the installed base of approximately 5,000 ThermoBrite instruments and will significantly enhance our competitive position in the high growth cytogenetic instrumentation market."

Robert Mello, president of the division, added that expanding its relationship with Fisher "provides a significant domestic sales channel for the ThermoBrite Elite and our future molecular products in this fast growing market."

Iris said that the target market for the instrument is the approximately 4,000 laboratories globally in the clinical and research market that offer FISH testing.

Financial and other terms of the deal were not disclosed.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.